Answers are grounded in this paper and cite their sources.
The purpose of our study was to analyze the relationship between serum FSH levels and TC, TG, LDL-C, HDL-C in postmenopausal T2DM patients and further explore the potential molecular mechanisms of FSH affecting lipid metabolism in postmenopausal T2DM via data mining online databases for associations between FSH and Dyslipidemia. Methods used in this paper. The first was a retrospective study of 279 postmenopausal patients with natural gestational type 2 diabetes mellitus (T2DM) admitted to the Department of Endocrinology of the First People's Hospital of Jining City from October 2020 to October 2022. Secondly, target genes for postmenopausal T2DM and lipid metabolism complications were retrieved from GeneCard, OMIM and GEO databases. Compound-target, protein-protein interaction (PPI) and compound-target-pathway networks were created using Cytoscape software. GO and KEGG pathway analyses were also performed to identify possible enrichment of genes with specific biological themes. The results obtained in this study are the age group of 50 to 60 years was demonstrated to have the most significant FSH levels in postmenopausal T2DM patients. Compared with the low FSH group, the TG level in the high FSH group significantly increased (P<0.05). The GeneCards database selected 2,113 pathogenic targets for T2DM, 878 targets for the postmenopausal period, and 335 pathogenic targets for dyslipidemia. Among them, INS, ALB, IL-6, TNF, PPARG, LEP, ADIPOQ, APOE, CRP, and APOB ranked in the top 10 nodes in terms of degree value and the AGE-RAGE signaling pathway dominated the KEGG signaling pathway. Further investigation in postmenopausal T2DM patients aged 50 to 60 years demonstrated a favorable connection between serum TG, FSH, IL-6.We conclude that, first, The FSH level reaches its peak secretion period in postmenopausal T2DM patients aged 50-60 years. Second, Serum TG levels in postmenopausal T2DM patients aged 50-60 are positively correlated with FSH. Third, FSH may exacerbate lipid metabolism disorders in postmenopausal T2DM patients aged 50-60 by activating the inflammatory cytokine IL-6.Fourth, AGE-RAGE, AMPK, and TNF signaling pathways may lead to abnormal blood lipids in postmenopausal T2DM.
No takes yet. Share an insight, caveat, or question.
Gong et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: